- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/19 - InterferonsLymphokinesCytokines
Patent holdings for IPC class C12N 15/19
Total number of patents in this class: 194
10-year publication summary
15
|
3
|
15
|
9
|
22
|
21
|
20
|
13
|
6
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 19857 |
5 |
National University Corporation Kanazawa University | 245 |
5 |
Regeneron Pharmaceuticals, Inc. | 4242 |
5 |
Nissan Chemical Corporation | 2000 |
5 |
Genentech, Inc. | 3979 |
4 |
Chugai Seiyaku Kabushiki Kaisha | 1348 |
4 |
Institute for Research in Biomedicine (IRB) | 40 |
4 |
University of Pittsburgh - Of the Commonwealth System of Higher Education | 3137 |
4 |
Yale University | 2368 |
4 |
Actym Therapeutics, Inc. | 30 |
4 |
Apollo Life Sciences Limited | 11 |
3 |
Knc Laboratories Co., Ltd. | 37 |
3 |
Kyoto University | 2798 |
3 |
OncoMed Pharmaceuticals, Inc. | 76 |
3 |
Sunshine Lake Pharma Co., Ltd. | 596 |
3 |
University Health Network | 1038 |
3 |
Warsaw Orthopedic, Inc. | 3033 |
2 |
The Trustees of Columbia University in the City of New York | 3563 |
2 |
Kagoshima University | 308 |
2 |
NGM Biopharmaceuticals, Inc. | 179 |
2 |
Other owners | 124 |